VePesid
- Product NDC
- 69238-2811
- 11-digit product format
- 692382811
- Labeler code
- 69238
- Product ID
- 69238-2811_254bddbd-10bf-4415-a1a1-bae57127edc5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etoposide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals NY LLC
- Application
- NDA019557
- Marketing category
- NDA
- Marketing start
- 2026-05-15
- Substance
- ETOPOSIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- VePesid
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ETOPOSIDE | 50 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 6PLQ3CP4P3 |
| Rxcui | 105592, 197687 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906 | Product name | 7 | 20210625 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 2ab98334-79be-46be-f4f5-d4a6cc04219e | Product name | 3 | 20180118 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 4896aaa2-df52-a28b-a484-cf928e9408ca | Product name | 1 | 20140508 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| e9a73b62-e9c6-118b-a3be-022705d13855 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69238-2811-2 | VePesid | 20 in 1 CARTON | CAPSULE | 20 | 2 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197687 | etoposide 50 MG Oral Capsule | PSN | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
| 105592 | VePesid 50 MG Oral Capsule | PSN | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
| 105592 | etoposide 50 MG Oral Capsule [Vepesid] | SBD | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
| 197687 | etoposide 50 MG Oral Capsule | SCD | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
| 105592 | Vepesid 50 MG Oral Capsule | SY | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
| 197687 | VP-16 50 MG Oral Capsule | SY | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
| 105592 | VP-16 50 MG Oral Capsule [Vepesid] | SY | 2a40f3ed-4a36-4616-af6c-b616140fd5ee | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69238-2811-2 | 69238281102 | 20 CAPSULE in 1 CARTON (69238-2811-2) | 20 capsule | 2026-05-15 | No | No | Current |